Pnc Financial Services Group, Inc. Concert Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$5.71 - $9.22 $62 - $101	-11 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$9.44 - $13.12 $103 - $144	11 New	11 $0
Q4 2017 Feb 09, 2018	SELL	$13.96 - $29.05 $3.42 Million - $7.13 Million	-245,337 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$13.91 - $15.31 $3.41 Million - $3.76 Million	245,337	245,337 $0

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.